PubRank

John Suh

Author PubWeight™ 26.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2009 6.11
2 Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2011 4.12
3 Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003 2.69
4 Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 2011 1.74
5 Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol 2013 1.12
6 Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. Int J Radiat Oncol Biol Phys 2005 1.09
7 Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14. J Palliat Med 2008 0.98
8 RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. J Clin Oncol 2003 0.98
9 The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol 2013 0.94
10 Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714. Int J Radiat Oncol Biol Phys 2009 0.93
11 Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases. Am J Clin Oncol 2007 0.92
12 The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making. J Neurosurg 2006 0.90
13 The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme. Technol Cancer Res Treat 2004 0.88
14 Chromosome 1p and 19q deletions in glioblastoma multiforme. Appl Immunohistochem Mol Morphol 2009 0.88
15 Coexistence of a pituitary macroadenoma and pheochromocytoma--a case report and review of the literature. Pituitary 2003 0.83
16 Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys 2007 0.82
17 Postoperative stereotactic radiosurgery for resected brain metastasis. CNS Oncol 2014 0.79
18 Stereotactic body radiotherapy: a new paradigm in the management of spinal metastases. CNS Oncol 2013 0.77
19 Confirmatory factor analysis of brief pain inventory (BPI) functional interference clusters in patients with bone metastases. J Pain Manag 2010 0.75
20 In regard to Yamamoto et al. Int J Radiat Oncol Biol Phys 2012 0.75
21 The current state of emergency medical training in US schools of podiatric medicine. J Am Podiatr Med Assoc 2015 0.75